Susan Graf

Presidente en FINCH THERAPEUTICS GROUP, INC. .

Fortuna: 374 $ al 30/04/2024

52 años

84 relaciones

Health Technology

Consumer Services

Health Services

Relaciones activas

Nombre	Sexo	Edad	Empresas relacionadas	Colaboración
Ronald D. Gunn	M	63	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Arthur Kuan	M	34	CG ONCOLOGY, INC.	7 años
Chris Shumway	M	58	FINCH THERAPEUTICS GROUP, INC.	4 años
Elder Granger	M	70	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	2 años
Victor Tong	M	41	CG ONCOLOGY, INC.	1 años
Hong Fang Song	F	59	CG ONCOLOGY, INC.	9 años
Ned Ruffin	M	-	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Jeffery Smisek	M	69	FINCH THERAPEUTICS GROUP, INC.	7 años
James Mulé	M	72	CG ONCOLOGY, INC.	6 años
Ambaw Bellete	M	54	CG ONCOLOGY, INC.	1 años
Christian Lange	M	44	FINCH THERAPEUTICS GROUP, INC.	7 años
Michael Wells	M	55	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Domenic Ferrante	M	58	FINCH THERAPEUTICS GROUP, INC.	5 años
Leonard Post	M	72	CG ONCOLOGY, INC.	6 años
Brian Liu	M	36	CG ONCOLOGY, INC.	2 años
Matthew Nelson	M	-	FINCH THERAPEUTICS GROUP, INC.	3 años
Randy Raisman	M	-	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Jim Lenehan	M	-	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	-
Matthew Blischak	M	-	FINCH THERAPEUTICS GROUP, INC.	1 años
Vijay Kasturi	M	57	CG ONCOLOGY, INC.	1 años
Lance Thibault	M	58	FINCH THERAPEUTICS GROUP, INC.	1 años
Sonia Timberlake	M	-	FINCH THERAPEUTICS GROUP, INC.	-
Erin Graves	M	-	EPIZYME, INC.	7 años
Michelle L. Rose	M	-	FINCH THERAPEUTICS GROUP, INC.	-
Bing Kung	M	-	CG ONCOLOGY, INC.	-
Evan Bedil	M	-	Kaleo, Inc. Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA.	3 años
Swapnil Bhargava	M	-	CG ONCOLOGY, INC.	1 años

Gráfico relacional

Relaciones con varias empresas

Antiguas relaciones

Nombre	Sexo	Edad	Empresas relacionadas	Colaboración
Andrew Singer	M	53	EPIZYME, INC.	2 años
Suzanne Fleming	F	63	EPIZYME, INC.	2 años
Matthew Ros	M	57	EPIZYME, INC.	5 años
Andrew Noh	M	-	FINCH THERAPEUTICS GROUP, INC.	4 años
Mark Smith	M	37	FINCH THERAPEUTICS GROUP, INC.	6 años
Marc Blaustein	M	61	FINCH THERAPEUTICS GROUP, INC.	2 años
Francois Nader	M	67	NPS PHARMACEUTICALS, INC.	7 años
Joseph Vittiglio	M	52	FINCH THERAPEUTICS GROUP, INC.	2 años
Edward H. Stratemeier	M	75	NPS PHARMACEUTICALS, INC.	5 años
Joseph Beaulieu	M	43	EPIZYME, INC.	5 años
Christine Cvijic	F	46	NPS PHARMACEUTICALS, INC.	1 años
Pedro Granadillo	M	77	NPS PHARMACEUTICALS, INC.	5 años
Julie DiCarlo	F	-	EPIZYME, INC.	-
Brendan P. Rae	M	-	NPS PHARMACEUTICALS, INC.	1 años
Zain Kassam	M	42	FINCH THERAPEUTICS GROUP, INC.	4 años
Nicholas Haft	M	35	FINCH THERAPEUTICS GROUP, INC.	3 años
Anne Marie Conway	F	-	FINCH THERAPEUTICS GROUP, INC.	-
Christine Mikail,	-	-	NPS PHARMACEUTICALS, INC.	1 años
Samuel Hamood	M	56	FINCH THERAPEUTICS GROUP, INC.	-
Colin Broom	M	68	NPS PHARMACEUTICALS, INC.	6 años
Roger Garceau	M	70	NPS PHARMACEUTICALS, INC.	7 años
Michael Bonney	M	65	NPS PHARMACEUTICALS, INC.	10 años
Tai Ching Ho	M	62	EPIZYME, INC.	3 años
Kevin Conroy	M	58	EPIZYME, INC.	5 años
Gregory Perry	M	63	FINCH THERAPEUTICS GROUP, INC.	4 años
John F. Weidenbruch	M	63	EPIZYME, INC.	5 años
Shefali Agarwal	M	50	EPIZYME, INC.	4 años
Debra Silberg	M	-	FINCH THERAPEUTICS GROUP, INC.	-
Vishal Kapoor	M	48	NPS PHARMACEUTICALS, INC.	1 años
Andrea Edwards	F	-	EPIZYME, INC.	3 años
Jason Fredette	M	-	EPIZYME, INC.	-
Chris Weidenmaier	M	-	FINCH THERAPEUTICS GROUP, INC.	-
John Bishop	M	62	EPIZYME, INC.	4 años
David Rhodes	M	-	FINCH THERAPEUTICS GROUP, INC.	3 años
Ralf H. Rosskamp	M	71	NPS PHARMACEUTICALS, INC.	2 años
David Pugatch	M	-	FINCH THERAPEUTICS GROUP, INC.	2 años
Robert Copeland	M	-	EPIZYME, INC.	9 años
Bryan Gillis	M	-	FINCH THERAPEUTICS GROUP, INC.	1 años
Zoran Zdraveski	M	54	EPIZYME, INC.	5 años
Eric Pauwels	M	63	NPS PHARMACEUTICALS, INC.	4 años
Marcio Souza	M	45	NPS PHARMACEUTICALS, INC.	2 años
Alka Batycky	M	54	FINCH THERAPEUTICS GROUP, INC.	1 años
Scott Wilhoit	M	61	NPS PHARMACEUTICALS, INC.	2 años
Susan M. Mesco	F	-	NPS PHARMACEUTICALS, INC.	7 años
Pierre Legault	M	63	NPS PHARMACEUTICALS, INC.	1 años
Robin D. Friedman	F	-	NPS PHARMACEUTICALS, INC.	1 años
Kenneth Bahrt	M	71	NPS PHARMACEUTICALS, INC.	1 años
Luke Beshar	M	65	NPS PHARMACEUTICALS, INC.	8 años
Ellen Rosenberg	F	61	NPS PHARMACEUTICALS, INC.	-
Alyssa Wyant	F	49	NPS PHARMACEUTICALS, INC.	3 años
Pamela Strode	F	-	EPIZYME, INC.	3 años
Glenn R. Melrose	M	68	NPS PHARMACEUTICALS, INC.	2 años
Dhiren D'silva	M	-	NPS PHARMACEUTICALS, INC.	2 años
Rebecca Cohen	F	-	EPIZYME, INC.	-
Patrik Florencio	M	-	NPS PHARMACEUTICALS, INC.	1 años
Paul Firuta	M	58	NPS PHARMACEUTICALS, INC.	1 años
Leah Neufeld	F	51	NPS PHARMACEUTICALS, INC.	1 años

Estadísticas

País	Relaciones	% del total
Estados Unidos	84	100.00%

Antigüedad de la relación

Activas

Pasados

Hombre

Mujer

Administradores

Ejecutivos

Origen de las relaciones